RecruitingNasopharyngeal Cancer Recurrent
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
Eligible age
12+ yrs
Accepts
All genders
Locations
9 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study aims to investigate toripalimab with chemotherapy in participants with nasopharyngeal cancer.
Sponsor: Coherus Oncology, Inc.
Where it's recruiting
Arkansas
Little Rock
California
Irvine · San Francisco
Georgia
Atlanta
Massachusetts
Boston
Michigan
Ann Arbor · Detroit
New York
New York
Ohio
Cincinnati · Cleveland
Pennsylvania
Hershey
Wisconsin
Milwaukee
Source: ClinicalTrials.gov · NCT06457503 · last updated 2026-07-30